Oman- Al Hashar Pharmacy, Capital Pharmacy attain ISO 9001:2015 certification


(MENAFN- Muscat Daily) Muscat- Al Hashar Pharmacy and sister company, Capital Pharmacy (a division of Transworld for Marketing and Trading), the leading pharmaceutical distributors in Oman, unveiled the ISO/9001:2015 certificates at a glittering event at Crowne Plaza Muscat recently.

Al Hashar Pharmacy has been at the forefront of healthcare for 45 years, representing world-class manufacturers such as Eli Lilly, US, Sanofi, France, Roche Diabetes Care, Neopharma, UAE, Menarini, Italy, etc marketing their world-class products for the benefit of patients in Oman.

Besides the widespread pharmaceutical distribution network throughout Oman having medical stores in Muscat, Sohar and Salalah, Al Hashar Pharmacy is also into clinical and industry diagnostic segments with its medical equipment and reagents that provide state-of-the-art diagnosis of patient pathologies.

The sister company Capital Pharmacy also represents several international manufacturers in the pharmaceutical and nutraceutical space. In the presence of distinguished guests that included the companies' key stakeholders, the certificates were presented to Al Hashar Pharmacy chairman, Shk Nasser Mohammed al Hashar, and director of Al Hashar and Capital Pharmacies, Shk Nasser Said al Hashar, by the Bureau Veritas country manager, John Rosario. Suresh Gandhi, CEO, said, 'Our philosophy continued to remain 'Together we will win as a team'.'

The ISO awards ceremony started off with a video that highlighted the company's achievements and contributions since its inception towards the growth of Oman and especially its healthcare. The 45th anniversary video was followed by a welcome address delivered by Gandhi.

MENAFN2310201701410000ID1095979819


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.